1. Busser J, Geldmacher DS, Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci 1998;18:2801-2807. PMID:
9525997.
2. McShea A, Lee HG, Petersen RB, Casadesus G, Vincent I, Linford NJ, et al. Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. Biochim Biophys Acta 2007;1772:467-472. PMID:
17095196.
3. Nuydens R, de Jong M, Van Den Kieboom G, Heers C, Dispersyn G, Cornelissen F, et al. Okadaic acid-induced apoptosis in neuronal cells: evidence for an abortive mitotic attempt. J Neurochem 1998;70:1124-1133. PMID:
9489733.
4. Raina AK, Zhu X, Rottkamp CA, Monteiro M, Takeda A, Smith MA. Cyclin' toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. J Neurosci Res 2000;61:128-133. PMID:
10878584.
5. Vincent I, Jicha G, Rosado M, Dickson DW. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci 1997;17:3588-3598. PMID:
9133382.
6. Yang Y, Mufson EJ, Herrup K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J Neurosci 2003;23:2557-2563. PMID:
12684440.
7. Arendt T, Rodel L, Gartner U, Holzer M. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport 1996;7:3047-3049. PMID:
9116237.
8. Kondratick CM, Vandre DD. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes. J Neurochem 1996;67:2405-2416. PMID:
8931473.
9. Hoozemans JJ, Bruckner MK, Rozemuller AJ, Veerhuis R, Eikelenboom P, Arendt T. Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex. J Neuropathol Exp Neurol 2002;61:678-688. PMID:
12152783.
10. Nagy Z, Combrinck M, Budge M, McShane R. Cell cycle kinesis in lymphocytes in the diagnosis of Alzheimer's disease. Neurosci Lett 2002;317:81-84. PMID:
11755245.
11. Sultana R, Mecocci P, Mangialasche F, Cecchetti R, Baglioni M, Butterfield DA. Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder. J Alzheimers Dis 2011;24:77-84. PMID:
21383494.
12. Leuner K, Schulz K, Schutt T, Pantel J, Prvulovic D, Rhein V, et al. Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes. Mol Neurobiol 2012;46:194-204. PMID:
22821186.
13. Behrens MI, Silva M, Salech F, Ponce DP, Merino D, Sinning M, et al. Inverse susceptibility to oxidative death of lymphocytes obtained from Alzheimer's patients and skin cancer survivors: increased apoptosis in Alzheimer's and reduced necrosis in cancer. J Gerontol A Biol Sci Med Sci 2012;67:1036-1040. PMID:
22367434.
14. Urcelay E, Ibarreta D, Parrilla R, Ayuso MS, Martin-Requero A. Enhanced proliferation of lymphoblasts from patients with Alzheimer dementia associated with calmodulin-dependent activation of the na+/H+ exchanger. Neurobiol Dis 2001;8:289-298. PMID:
11300724.
16. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 2000;59:23-30. PMID:
10961414.
17. Kang Y, Na DL, Hahn S. A validity study on the Korean Mini-Mental Status Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc 1997;15:300-308.
18. Ku HM, Kim JH, Kwon EJ, Kim SH, Lee HS, Ko HJ, et al. A study on the reliability and validity of Seoul-Instrumental Activities of Daily Living (S-IADL). J Korean Neuropsychiatr Assoc 2004;43:189-199.
19. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414. PMID:
8232972.
20. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571. PMID:
13688369.
21. Rusk R, Hyerstay BJ, Calsyn DA, Freeman CW. Comparison of the utility of two abbreviated forms of the MMPI for psychiatric screening of the elderly. J Clin Psychol 1979;35:104-107. PMID:
422712.
22. Arbogast A, Boutet S, Phelouzat MA, Plastre O, Quadri R, Proust JJ. Failure of T lymphocytes from elderly humans to enter the cell cycle is associated with low Cdk6 activity and impaired phosphorylation of Rb protein. Cell Immunol 1999;197:46-54. PMID:
10555995.
23. Boonstra J. Progression through the G1-phase of the on-going cell cycle. J Cell Biochem 2003;90:244-252. PMID:
14505341.
24. Sanchez I, Dynlacht BD. New insights into cyclins, CDKs, and cell cycle control. Semin Cell Dev Biol 2005;16:311-321. PMID:
15840440.
25. Coqueret O. Linking cyclins to transcriptional control. Gene 2002;299:35-55. PMID:
12459251.
26. Giovanni A, Wirtz-Brugger F, Keramaris E, Slack R, Park DS. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death. J Biol Chem 1999;274:19011-19016. PMID:
10383401.
27. Arellano M, Moreno S. Regulation of CDK/cyclin complexes during the cell cycle. Int J Biochem Cell Biol 1997;29:559-573. PMID:
9363633.
28. Morgan DO. Principles of CDK regulation. Nature 1995;374:131-134. PMID:
7877684.
29. Felten DL, Felten SY, Bellinger DL, Carlson SL, Ackerman KD, Madden KS, et al. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol Rev 1987;100:225-260. PMID:
3326822.
30. Gladkevich A, Kauffman HF, Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:559-576. PMID:
15093964.
31. Kadioglu E, Sardas S, Aslan S, Isik E, Esat Karakaya A. Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer's disease. Biomarkers 2004;9:203-209. PMID:
15370876.
32. Mecocci P, Polidori MC, Ingegni T, Cherubini A, Chionne F, Cecchetti R, et al. Oxidative damage to DNA in lymphocytes from AD patients. Neurology 1998;51:1014-1017. PMID:
9781522.
33. Sulger J, Dumais-Huber C, Zerfass R, Henn FA, Aldenhoff JB. The calcium response of human T lymphocytes is decreased in aging but increased in Alzheimer's dementia. Biol Psychiatry 1999;45:737-742. PMID:
10188003.
34. Tacconi S, Perri R, Balestrieri E, Grelli S, Bernardini S, Annichiarico R, et al. Increased caspase activation in peripheral blood mononuclear cells of patients with Alzheimer's disease. Exp Neurol 2004;190:254-262. PMID:
15473998.
35. Velez-Pardo C, Ospina GG, Jimenez del Rio M. Abeta[25-35] peptide and iron promote apoptosis in lymphocytes by an oxidative stress mechanism: involvement of H2O2, caspase-3, NF-kappaB, p53 and c-Jun. Neurotoxicology 2002;23:351-365. PMID:
12387362.
36. de las Cuevas N, Urcelay E, Hermida OG, Saiz-Diaz RA, Bermejo F, Ayuso MS, et al. Ca2+/calmodulin-dependent modulation of cell cycle elements pRb and p27kip1 involved in the enhanced proliferation of lymphoblasts from patients with Alzheimer dementia. Neurobiol Dis 2003;13:254-263. PMID:
12901840.
37. Muñoz U, Bartolome F, Bermejo F, Martin-Requero A. Enhanced proteasome-dependent degradation of the CDK inhibitor p27(kip1) in immortalized lymphocytes from Alzheimer's dementia patients. Neurobiol Aging 2008;29:1474-1484. PMID:
17448572.
38. Zana M, Juhasz A, Rimanoczy A, Bjelik A, Baltas E, Ocsovszki I, et al. Alzheimer's lymphocytes are resistant to ultraviolet B-induced apoptosis. Neurobiol Aging 2006;27:831-834. PMID:
15961188.
39. Husseman JW, Nochlin D, Vincent I. Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases. Neurobiol Aging 2000;21:815-828. PMID:
11124425.
40. Timsit S, Rivera S, Ouaghi P, Guischard F, Tremblay E, Ben-Ari Y, et al. Increased cyclin D1 in vulnerable neurons in the hippocampus after ischaemia and epilepsy: a modulator of in vivo programmed cell death? Eur J Neurosci 1999;11:263-278. PMID:
9987030.
41. van Lookeren Campagne M, Gill R. Increased expression of cyclin G1 and p21WAF1/CIP1 in neurons following transient forebrain ischemia: comparison with early DNA damage. J Neurosci Res 1998;53:279-296. PMID:
9698156.